Investor Relations

Splash Graphic

Investment Offering

Through Investor Relations, Irvine Therapeutics is offering stock to investors while increasing focus and development of clinical studies, trials and data from EpileneĀ® and Procanol®.

Splash Graphic

Irvine Therapeutics Inc. is a wholly owned subsidiary of Procana Holdings Inc.
Current stock offering is available to accredited investors at $1.12 per share with a minimum investment of $25,000. For more information, and to receive an offering prospectus please email:

Contact Form